Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (16487)	11/23/2003 11:39:33 PM
From: Bluegreen	Respond to of 17367

George, us beggars can't be so choosy!!!!!!!LOL

To: aknahow who wrote (16487)	11/24/2003 1:07:49 AM
From: Bluegreen	Read Replies (1) \| Respond to of 17367

George, another piece of the puzzle>>>>>>>>http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14623259&dopt=Abstract

To: aknahow who wrote (16487)	11/28/2003 9:39:58 PM
From: Bluegreen	Respond to of 17367

EXTRA!!!! EXTRA!!!!!!!! READ ALL ABOUT IT!!!! LOOK HOW MANY PATIENTS THIS PHYSICIAN HAS TREATED WITH RAPTIVA!!!! WOW!!!!!!!!!!!!! How many Dermatologists are going to be treating this many???? Does this indicate tip of iceberg of people with moderate to severe psoriasis that will DEMAND Raptiva?????? When will we see December scripts written for Raptiva???? >>>>>>>>>http://www.thebakersfieldchannel.com/health/2588177/detail.html